Mark Mendeszoon
Foot & Ankle Surgery · Chardon, OHNPI 1356328538
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $123,133 of the $172,718 with a category attached, or 71.3%. 34 manufacturers reported payments, led by Orthofix Medical, Inc. at 51.1% of the total. Reporting peaked in 2023 at $51,967 and has fallen 81.2% since, to $9,747 in 2025. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 329 payments — averaging $524.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$88K
- Linvatec Corporation$18K
- In2bones USA, LLC$15K
- Royal Biologics, Inc.$11K
- Crossroads Extremity Systems, LLC$10K
- DNE LLC$9K
- plus $22K from 28 others
Across 1 payment — averaging $20,100 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$20K
Across 6 payments — averaging $4166.67 each. An ownership or investment interest held by the physician or an immediate family member.
- Gramercy Extremity Orthopedics LLC$25K
What the payments were for
- Royalty or licence$4,5993%
- Consulting fees$123,13371%
- Speaking & faculty fees$6,3714%
- Grants$2,5001%
- Travel & lodging$26,94416%
- Food & beverage$9,1715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 122 | $88,291 |
| Linvatec Corporation | 26 | $18,484 |
| In2bones USA, LLC | 14 | $14,819 |
| Royal Biologics, Inc. | 18 | $10,559 |
| Crossroads Extremity Systems, LLC | 10 | $9,559 |
| DNE LLC | 3 | $8,984 |
| Integra Lifesciences Corporation | 18 | $5,407 |
| Medshape, Inc. | 10 | $4,990 |
| Stryker | 42 | $2,153 |
| Ascension Orthopedics, Inc. | 5 | $2,040 |
| Smith+Nephew | 16 | $2,039 |
| Trilliant Surgical LLC. | 1 | $1,260 |
| Medtronic | 7 | $1,117 |
| Novastep Inc. | 4 | $970 |
| Medline Industries LP | 4 | $733 |
| Gramercy Extremity Orthopedics LLC | 1 | $475 |
| Biotissue Holdings Inc. | 2 | $162 |
| Restor3d, Inc. | 1 | $143 |
| Nevro Corp. | 4 | $120 |
| Averitas Pharma Inc. | 3 | $77 |
| Vericel Corporation | 3 | $49 |
| Johnson & Johnson | 1 | $44 |
| Rock Medical Orthopedics, Inc. | 1 | $40 |
| Moximed, Inc | 2 | $29 |
| Zyla Life Sciences, Inc. | 2 | $27 |
| Triad Life Sciences Inc. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Bioventus LLC | 1 | $17 |
| Davol Inc. | 1 | $16 |
| Solventum Corporation | 1 | $16 |
| Organogenesis Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Globus Medical | 1 | $14 |
| Hydrocision, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$34,057
- JUNIORTHO PLATING SYSTEM$22,002
- TL-HEX$13,298
- TrueLok Ring Fixation System$11,142
- Hercules$10,890
- GALAXY FIXATION SYSTEM$10,744
- Veronail Titanium Trochanteric Nail$10,125
- XCaliber Articulated Ankle Fixator$10,125
- XCaliber Hybrid Fixator$10,125
- SEAL$8,984
- QUANTUM$7,818
- CADENCE ANKLE REPLACEMENT SYSTEM$6,516
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$6,516
- PANTA NAIL$6,516
- TOTAL FOOT SYSTEM$6,516
- Pennig Dynamic Wrist Fixator$6,516
- CoLink$6,190
- NeoSpan$6,082
- Centronail Titanium Supracondylar and Retrograde Nail$5,962
- Small DAF$4,875
How this compares
$172,718 in reported general payments places this provider in the 95th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 24 | $1,075 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $535 |
| Gabapentin | 36 | $407 |
| Doxycycline Monohydrate | 27 | $367 |
| Betamethasone Valerate | 12 | $298 |
| Cephalexin | 96 | $238 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $153 |
| Amitriptyline Hcl | 13 | $144 |
| Meloxicam | 24 | $122 |
| Ammonium Lactate | 12 | $117 |
| Tramadol Hcl | 20 | $48 |
| Azithromycin | 17 | $42 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Chardon
- Christopher HyerWorthington$4.7M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.2M
- Lee HladGahanna$440K
- Windy ColeKent$431K
- Elizabeth HewittGrove City$414K
- Dominic RizzoBlue Ash$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.